{"metadata": {"organization_names": ["davis polk & wardwell"], "person_names_verified": [], "organization_names_verified": ["citigroup global markets inc.", "lcd-ibd", "brinks hofer gilson & lione", "deloitte & touche", "credit suisse securities", "citigroup global markets inc", "alimera sciences, inc.", "gunderson dettmer stough"], "vars": {"Party": {"Sarbanes-Oxley": "[[Party 2]]", "incorporated": "[[Party 1]]"}}, "entities_rejected": [], "person_names": [], "agreement_id": "2daf0bf6258ac2c4132889de15de26b0211f51abccd566769f9a0531b064f587", "topics": [], "terms": ["***Applicable Law***", "***Definitions***", "**ALIMERA SCIENCES, INC.**", "**Common Stock**", "**This Agreement shall be governed by, and construed in accordance with, the laws of the State of [[Address 8: Address]]**", "**UNDERWRITING AGREEMENT**", "**[Insert Number of Shares]**", "*Absence of Accounting Issues*", "*Absence of Defaults and Conflicts Resulting from Transaction*", "*Absence of Existing Defaults and Conflicts*", "*Absence of Fiduciary Relationship*", "*Absence of Further Requirements*", "*Absence of Labor Dispute*", "*Absence of Manipulation*", "*Absence of Obligation to Disclose*", "*Absence of Unlawful Influence.*", "*Accountants\u2019 Comfort Letter*", "*Accurate Disclosure*", "*Actions against Parties; Notification*", "*Additional Filings*", "*Additional Officer\u2019s Certificate*", "*Arms\u2019 Length Negotiations*", "*Authorization of Agreement*", "*Blue Sky Qualifications*", "*Certain Agreements of the Company*", "*Compliance with Foreign Laws.*", "*Compliance with Money Laundering Laws*", "*Compliance with Securities Act Requirements*", "*Conditions of the Obligations of the Underwriters*", "*Continued Compliance with Securities Laws*", "*Contribution*", "*Counterparts*", "*Default of Underwriters*", "*Effectiveness of Registration Statement*", "*Environmental Laws*", "*FCPA.*", "*Filing and Effectiveness of Registration Statement; Certain Defined Terms*", "*Filing of Amendments: Response to Commission Requests*", "*Financial Statements*", "*Free Writing Prospectuses*", "*Furnishing of Prospectuses*", "*General Disclosure Package*", "*Good Standing of the Company*", "*Indemnification and Contribution.*", "*Indemnification of Company*", "*Indemnification of Underwriters by Company*", "*Ineligible Issuer Status*", "*Insurance*", "*Intellectual Property*", "*Internal Controls and Compliance with the [[Board]] Act*", "*Introductory*", "*Investment Company Act*", "*Issuer Free Writing Prospectuses*", "*Listing*", "*Litigation*", "*Lock-Up Agreements*", "*No Finder\u2019s Fee*", "*No Material Adverse Change in Business*", "*No Material Adverse Change*", "*No Other Relationship*", "*Notices*", "*OFAC*", "*Offered Securities; Capitalization*", "*Offering by Underwriters*", "*Officer\u2019s Certificate*", "*Opinion of Counsel for Underwriters*", "*Opinion of Counsel for the Company*", "*Opinion of Patent Counsel for the Company*", "*PFIC Status*", "*Payment of Expenses Related to Directed Share Program.*", "*Payment of Expenses*", "*Possession of Licenses and Permits*", "*Preclinical and Clinical Trials*", "*Purchase, Sale and Delivery of Offered Securities*", "*Ratings*", "*Registration Rights*", "*Reporting Requirements*", "*Representation*", "*Representations and Warranties of the Company*", "*Restriction on Sale of Securities by Company*", "*Rule 158*", "*Statistical and Market-Related Data*", "*Subsidiaries*", "*Successors*", "*Survival of Certain Representations and Obligations*", "*Taxation*", "*Term Sheets*", "*Title to Property*", "*Transfer Restrictions.*", "*Use of Proceeds*", "*Waiver*", "\u201c**430A Information**", "\u201c**Act**\u201d", "\u201c**Additional Registration Statement**", "\u201c**Applicable Time**\u201d", "\u201c**Audit Committee**\u201d", "\u201c**Availability Date**\u201d", "\u201c**Board**\u201d", "\u201c**Closing Date**\u201d", "\u201c**Commission**\u201d", "\u201c**Company**\u201d", "\u201c**Debt Repayment Triggering Event**\u201d", "\u201c**Designated Entities**\u201d", "\u201c**Designated Underwriter**\u201d", "\u201c**Directed Share Program**\u201d", "\u201c**Directed Shares**\u201d", "\u201c**EDGAR**\u201d", "\u201c**Effective Time**\u201d", "\u201c**Environmental Laws**\u201d", "\u201c**Exchange Act**\u201d", "\u201c**Exchange Rules**\u201d", "\u201c**Final Prospectus**\u201d", "\u201c**Firm Securities**\u201d", "\u201c**First Closing Date**", "\u201c**GAAP**\u201d", "\u201c**General Disclosure Package**\u201d", "\u201c**General Use Issuer Free Writing Prospectus**\u201d", "\u201c**Indemnified Party**\u201d", "\u201c**Initial Registration Statement**", "\u201c**Intellectual Property Rights**\u201d", "\u201c**Internal Control Event**\u201d", "\u201c**Internal Controls**\u201d", "\u201c**Investment Company Act**\u201d", "\u201c**Issuer Free Writing Prospectus**\u201d", "\u201c**Licenses**\u201d", "\u201c**Limited Use Issuer Free Writing Prospectus**\u201d", "\u201c**Lock-Up Period**\u201d", "\u201c**Lock-Up Securities**\u201d", "\u201c**Material Adverse Effect**\u201d", "\u201c**Money Laundering Laws**\u201d", "\u201c**OFAC**\u201d", "\u201c**Offered Securities.**\u201d", "\u201c**Optional Closing Date**\u201d", "\u201c**Optional Securities**\u201d", "\u201c**PFIC**\u201d", "\u201c**Participants**\u201d", "\u201c**Permitted Free Writing Prospectus**", "\u201c**Registration Statement**", "\u201c**Registration Statement**\u201d", "\u201c**Registration Statements**\u201d", "\u201c**Representatives**\u201d", "\u201c**Rules and Regulations**\u201d", "\u201c**Securities Laws**\u201d", "\u201c**Securities**\u201d", "\u201c**Statutory Prospectus**\u201d", "\u201c**Underwriter Indemnified Party**\u201d", "\u201c**Underwriters**\u201d", "\u201c[[Board]]\u201d"]}}